Sun Yat-sen University

This study tests whether adding the targeted drug apatinib to standard chemotherapy and radiation can help people with advanced esophageal cancer that cannot be removed by surgery. About 170 participants will receive either the standard treatment or the standard treatment plus ap…

This study tests whether using smaller radiation targets after chemotherapy can control advanced nasopharyngeal cancer while reducing side effects. About 445 patients with stage III to IVa disease will receive standard chemotherapy followed by either standard or reduced radiation…

This study tests whether adding anlotinib hydrochloride to the standard Stupp regimen can help people with newly diagnosed glioblastoma, an aggressive brain cancer. About 150 adults aged 18-75 will receive either the combination or standard treatment alone. The main goal is to se…

This study looks at men whose prostate cancer has spread to nearby lymph nodes after surgery. Researchers want to see if adding pelvic radiation to 2 years of hormone therapy can delay the cancer from coming back or spreading. About 374 participants will be randomly assigned to r…

This study tests a combination of three drugs (anlotinib, penpulimab, and capecitabine) as a first treatment for people whose nasopharyngeal cancer has spread or returned. About 59 adults aged 18–65 with measurable tumors will receive the therapy. The main goal is to see how long…

This study tests a treatment plan for muscle-invasive bladder cancer that avoids removing the bladder. Patients first receive chemotherapy plus an immunotherapy drug (toripalimab), followed by radiation therapy with more immunotherapy. The goal is to see if this combination can d…

This study looks at whether giving a small dose of morphine into the spine before laparoscopic colon cancer surgery can improve how well patients feel and recover afterward. About 252 adults having this surgery will be invited to take part. The goal is to see if this approach red…